EX-23.1 4 ea150419ex23-1_altamira.htm CONSENT OF DELOITTE AG

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form F-3 of our report dated March 31, 2021 relating to the financial statements of Altamira Therapeutics Ltd. (formerly Auris Medical Holding Ltd.), appearing in the Annual Report on Form 20-F of Altamira Therapeutics Ltd. for the year ended December 31, 2020. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

Deloitte AG

 

/s/ Rolland Mueller   /s/ Adrian Kaeppeli

 

Zurich, Switzerland

November 15, 2021